Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
3.960
+0.160 (4.21%)
At close: Mar 4, 2026, 4:00 PM EST
3.936
-0.024 (-0.60%)
After-hours: Mar 4, 2026, 7:56 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16
R&D of the Use of Psychedelic Medicine and Therapies
86.00K12.00K
---
R&D of the Use of Psychedelic Medicine and Therapies Growth
616.67%-
---
Medicinal Cannabis
--
539.05K1.42M417.62K
Medicinal Cannabis Growth
--
-62.11%240.67%-
Corporate
--
-54.78K-
Total
86.00K12.00K
539.05K1.48M417.62K
Total Growth
616.67%-
-63.52%253.78%38249.13%

Revenue by Geography

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16
Australia
86.00K12.00K
539.05K1.45M417.62K
Australia Growth
616.67%-
-62.84%247.40%38249.13%
Total
86.00K12.00K
539.05K1.45M417.62K
Total Growth
616.67%-
-62.84%247.40%38249.13%
Source: S&P Global Market Intelligence.